BHPG

What a great educational day we had and to see all the representation we have across the UK on #hepatology #pharmacy! We will have many more events in the future, join us if you haven’t. It’s only £20! basl.org.uk/index.cfm/memb…

Naltrexone should be first line for AUD in people with cirrhosis It is increasingly uncomfortable to see baclofen mentioned alongside it, or even acamprosate

Only 2 weeks left to our annual educational event in London! Have a look and sign up now to not miss your chance! Register here: execbs.eventsair.com/bhpg-meeting--…

Another successful year at #BASL2025! Great to see all the inspiring 💫 work from #pharmacy. See you all at the next BHPG meeting on 25 Nov! It’s 🆓 for BASL members! See details 👇 📍44 Hallam Street, London 🔗 execbs.eventsair.com/bhpg-meeting--… ℹ️ basl.org.uk/index.cfm/even…

The prognosis of liver disease depends on the extent of fibrosis, which is usually staged with the use of liver biopsy. The limitations of biopsy have led to the development of noninvasive tests, which Drs. Laurent Castera, Mary E. Rinella, and Emmanuel A. Tsochatzis review. Learn more: nej.md/4hwZMgj

Further information on the BASL website basl.org.uk or register via this link execbs.eventsair.com/bhpg-meeting--…

Complications of Proton Pump Therapy 💊 One of the best figures I’ve seen in a long time. On your next ward round or in the clinic think about whether your patient really needs to be on a PPI. #GITwitter #livertwitter #gutmicrobiome #AMR gastrojournal.org/article/s0016-…

🟢 10/14 | BASL × FG Special Issue “Personalised treatment is reshaping how we manage difficult autoimmune hepatitis.” 🧬 Optimised thiopurine therapy + metabolite monitoring now standard of care 💊 MMF established as leading 2nd-line — and viable 1st-line in select cases 🧪 Tacrolimus, infliximab & rituximab emerging for refractory disease 📰 Read the full review ➡️ fg.bmj.com/content/16/e1/… #AutoimmuneHepatitis #Hepatology #FGBASLSpecialIssue @basl_events @heppharm @livernursing @LiverAHPs @Liver4Lifeuk @f4liverresearch @IQILS_Liver @LiverTrust @EASLedu @EASLnews @BritSocGastro @BavenoCoop @BCLC_group @ILCAnews @APASLnews @liverfellow @my_ueg @UKCPAGastro @PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman @BSGtrainees @drkeithsiau @ebtapper @DrLChina @acv69cardenas @GeriKeane @jamesbmaurice @ClinicLiver

🔔 Useful tools and information for all pharmacists helping to write and implement clinical guidelines for #hepatology in 🇬🇧

Always lovely to hear great engagement and response from our efforts! ✨ @Yun_Pharmacist definitely outdid herself on summarising the use of GLP1RA and the future of MASLD therapy for all of us.

Posters @ #BASL2025: @ClaireBullen13 presents data on repatriating immunosuppression prescribing to referral hospitals, enabling transplant recipients access care closer to home and align with the #NHS 10 year plan ambitions. @CUH_CambsLiver @CUH_NHS

Posters @ #BASL2025: Hannah Hesketh presents data on terlipressin use in HRS-1 post MHRA alert. We are currently collecting more 🇬🇧 data on this topic, please contact leslie.wong1@nhs.net for more information. @geshNHS #research

Arron Jones presenting on current and emerging treatment options for #PBC, highlighting data collected from our group on elafibranor. #BASL2025 @NHSBartsHealth @PBCFoundation @BASLedu @LiverAHPs

Posters @#basl2025: Sinead Peare presents her data on @GSTTnhs #pharmacist led #HBV clinic, a valuable resource to the service in treating a vastly increasing patient cohort

Our vice chair Yun Jung Kim giving an excellent in depth talk on the current situation of GLP1RAs in #MASLD and how patients can access treatment. @BASLedu @LiverAHPs #BASL2025

Great to see so many delegates at #BASL2025! Perfect time to highlight our next event! Intro to hep day in London - 7th Nov 25 in London Link to registration: execbs.eventsair.com/basl-introduct…

Posters @ #BASL2025: @fatemajessa presents her work on a digital referral to drive efficiency in referring rifaximin patients to primary care, improving patient access in treating hepatic encephalopathy. @RoyalFreeNHS

Congrats to our research pharmacist Aaron Jones from Bart’s 🥇 on an excellent abstract and presentation on fracture risk in decomp cirrhosis @ #BASL2025.

@robelliotcooke representing #pharmacy on discussing challenges in treating #MASLD and promoting our future role in improving outcomes, such as initiating and titrating anti-diabetic/ 🫀medications and choosing appropriate antidepressants. #basl2025 @BASLedu @LiverAHPs